| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/4/264:02 PM | -$2.37 | -$1.90GAAP | +19.8% | -18% | $27.6M | $197.6M | ⚠ Check | — | |
| Q2 '26 | 8/5/264:02 PM | -$2.01 | -$3.06GAAP | -52.2% | -134% | $39.7M | $0 | ⚠ Check | — | |
| Q1 '26 | 5/6/264:02 PM | -$1.84 | -$2.29GAAP | -24.5% | -103% | $6.1M | $0 | ⚠ Check | — | |
| Q4 '25 | 2/25/264:02 PM | -$1.56 | -$1.86GAAP | -19.2% | -66% | $11.6M | $0 | ⚠ Check | — | |
| Q3 '25 | 11/5/254:02 PM | -$1.40 | -$1.61GAAP | -15.0% | -71% | $6.0M | $0 | ⚠ Check | — | |
| Q2 '25 | 8/6/254:02 PM | -$1.05 | -$1.31GAAP | -24.8% | -62% | $21.6M | $0 | ⚠ Check | — | |
| Q1 '25 | 5/7/254:02 PM | -$1.05 | -$1.13GAAP | -7.6% | -61% | — | $0 | — | — |
⚠ Potential error in calculation, check manually. The two revenue figures may be in different units or currencies. Reported revenue shows as zero, which usually means the figure is missing.
GAAP = diluted EPS as filed with the SEC.